In collaboration with

SPEAKERS

Committed Speakers to Date

Chris Anzalone Headshot

Chris Anzalone

Arrowhead Pharmaceuticals
Steve Harr Headshot

Steve Harr

Sana Biotechnology
David Julius Headshot
NOBEL

David Julius

University of California, San Francisco
Steve Harr Headshot

Jan Møller Mikkelsen

Ascendis Pharma
Robert Langer Headshot
BREAKTHROUGH

Robert Langer

MIT
May Britt Moser Headshot
NOBEL

May Britt Moser

Kavli Institute for Systems Neuroscience
May Britt Moser Headshot
PULITZER

Siddhartha Mukherjee

Columbia University
Guido Oelkers Headshot

Guido Oelkers

Sobi
Fred Ramsdell Headshot
NOBEL

Fred Ramsdell

Sonoma Biotherapeutics
Randy Schekman Headshot
NOBEL

Randy Schekman

University of California, Berkeley

AGENDA

Thursday
Sept 24, 2026
12:00 - 1:45 pm Welcome Lunch at Café Opera
2:00 - 5:00 pm Afternoon sessions at Operaterrassen
6:00 - 9:00 pm Welcome Reception at the Nobel Prize Museum
9:00 - 11:00 pm Supper and Nightcap at the Strand Rooftop Bar
Friday
Sept 25, 2026
8:15 am - 5:00 pm Daytime sessions and lunch at Operterrassen
5:15 - 6:00 pm Mini Harbor Cruise
6:00 - 9:00 pm Cocktails and Seated Dinner at Vasamuseet
9:00 - 11:00 pm Nightcap
Spouses and partners are warmly welcome to join conference delegates for the welcome lunch, opening reception, and closing dinner. Royalty Pharma has curated a parallel cultural and social program for accompanying spouses and partners on the afternoon of September 24 and throughout September 25.

LOCATIONS

NOBEL PRIZE MUSEUM

OPERATERRASSEN

CAFÉ OPERA

VASAMUSEET

STRAND HOTEL

BANK HOTEL

1 NOBEL PRIZE MUSEUM
3 CAFÉ OPERA
5 STRAND HOTEL
2 OPERATERRASSEN
4 VASAMUSEET
6 BANK HOTEL

ABOUT

The Accelerating Bio-Innovation (ABI) conference series was established in 2019 by Royalty Pharma to bring together leaders from academia, industry, and finance, and to inspire collaborations that transform discovery into impact.

Building on the success of the annual ABI gatherings in the US and UK – developed in collaboration with MIT and the University of Cambridge – ABI Sweden brings the series to a new setting shaped by the scientific legacy of the Karolinska Institute and the global significance of the Nobel Prize.

At the heart of each ABI is a distinctive program featuring world-class speakers and thought-provoking discussions. Equally central to ABI are curated social experiences that foster an environment for genuine connection and lasting relationships. Together these elements frame the ABI experience in an effort to advance discovery, innovation, and collaboration across the life sciences.

ABI Sweden Advisory Committee

Emelie Antoni Headshot

Emelie Antoni

AstraZeneca
Martin Bergö Headshot

Martin Bergö

Karolinska Institutet
Mikael Dolsten Headshot

Mikael Dolsten

Former Pfizer
Nina Kjellson Headshot

Nina Kjellson

Canaan
Siddhartha Mukherjee Headshot

Siddhartha Mukherjee

Columbia University
Thomas Perlmann Headshot

Thomas Perlmann

Nobel Assembly
Jim Reddoch Headshot

Jim Reddoch

Royalty Pharma
Anna Sjöström Douagi Headshot

Anna Sjöström Douagi

Nobel Prize Outreach
Mårten Steen Headshot

Mårten Steen

HealthCap
Molly Stevens Headshot

Molly Stevens

University of Oxford
Carl Johan Sundberg Headshot

Carl Johan Sundberg

Karolinska Institutet
Peter Svennilson Headshot

Peter Svennilson

The Column Group
Ulf Wiinberg Headshot

Ulf Wiinberg

Former Lundbeck

Past ABI Speakers have included

Scientific Luminaries

James Allison Headshot
NOBEL

James Allison

MD Anderson Cancer Center
Shankar Balasubramanian Headshot
BREAKTHROUGH

Shankar Balasubramanian

University of Cambridge
Carolyn Bertozzi Headshot
NOBEL

Carolyn Bertozzi

Stanford University
Allan Bradley Headshot

Allan Bradley

University of Cambridge
Craig Crews Headshot

Craig Crews

Yale University
Tyler Jacks Headshot

Tyler Jacks

Koch Institute for Integrative Cancer Research at MIT
Robert Langer Headshot
BREAKTHROUGH

Robert Langer

MIT
David Liu Headshot
BREAKTHROUGH

David Liu

Harvard
Patrick Maxwell Headshot

Patrick Maxwell

University of Cambridge
Craig Mello Headshot
NOBEL

Craig Mello

University of Massachusetts Medical School
Siddhartha Mukherjee Headshot
PULITZER

Siddhartha Mukherjee

Columbia University
Venkatraman Ramakrishna Headshot
NOBEL

Venkatraman Ramakrishnan

MRC Laboratory Of Molecular Biology
Michel Sadelain Headshot
BREAKTHROUGH

Michel Sadelain

Columbia University
Jude Samulski Headshot

Jude Samulski

Bamboo Therapeutics and Asklepios BioTherapeutics
Charles Sawyers Headshot
BREAKTHROUGH

Charles Sawyers

Memorial Sloan Kettering
Georg Schett Headshot

Georg Schett

FAU Erlangen-Nürnberg
Tim Springer Headshot

Tim Springer

Harvard Medical School
Phillip Sharp Headshot
NOBEL

Phillip Sharp

MIT
Kevan Shokat Headshot

Kevan Shokat

University of California, San Francisco
Eric Topol Headshot

Eric Topol

Scripps Research
Greg Winter Headshot
NOBEL

Greg Winter

University of Cambridge

Industry Leaders

Karen Akinsanya Headshot

Karen Akinsanya

Schrödinger
Deborah Baron Headshot

Deborah Baron

Pfizer
Arie Belldegrun Headshot

Arie Belldegrun

Kite
Robert Blum Headshot

Robert Blum

Cytokinetics
Karin Conde-Knape Headshot

Karin Conde-Knape

Novo Nordisk
Stan Crooke Headshot

Stan Crooke

n-Lorem Foundation
Robert M. Davis Headshot

Robert M. Davis

Merck & Co
Bassil Dahiyat Headshot

Bassil Dahiyat

Xencor
Henry Gosebruch Headshot

Henry Gosebruch

Abbvie
Yvonne Greenstreet Headshot

Yvonne Greenstreet

Alnylam Pharmaceuticals
Jane Grogan Headshot

Jane Grogan

Graphite Bio
Steve Harr Headshot

Steve Harr

Sana Biotechnology
Kate Haviland Headshot

Kate Haviland

Blueprint Medicines
Mary Lynne Hedley Headshot

Mary Lynne Hedley

Third Rock Ventures
Ying Huang Headshot

Ying Huang

Legend Biotech
William Lewis Headshot

William Lewis

Insmed
Ted Love Headshot

Ted Love

Global Blood Therapeutics
Mathai Mammen Headshot

Mathai Mammen

Former JNJ
Nello Mainolfi Headshot

Nello Mainolfi

Kymera Therapeutics
John Maraganore Headshot

John Maraganore

Richard Pazdur Headshot

Richard Pazdur

Center for Drug Evaluation and Research U.S. FDA
Andrew Plump Headshot

Andrew Plump

Takeda
David Redfern Headshot

David Redfern

GlaxoSmithKline
	David M. Reese Headshot

David M. Reese

Amgen
David A. Ricks Headshot

David A. Ricks

Eli Lilly and Company
Laura Shawver Headshot

Laura Shawver

Capstan Therapeutics
Pascal Soriot Headshot

Pascal Soriot

AstraZeneca
Marc Tessier-Lavigne Headshot

Marc Tessier-Lavigne

Xaira
Chris Viehbacher Headshot

Chris Viehbacher

Biogen
Tim Walbert Headshot

Tim Walbert

Horizon Therapeutics

Investors

Andy Acker Headshot

Andy Acker

Janus Henderson Investors
Srini Akkaraju Headshot

Srini Akkaraju

Samsara BioCapital
Michael Anstey Headshot

Michael Anstey

Cambridge Innovation Capital
Christiana Bardon Headshot

Christiana Bardon

MPM Capital
Kate Bingham Headshot

Kate Bingham

SV Health Managers
Tess Cameron Headshot

Tess Cameron

RA Capital
	Phill Gross Headshot

Phill Gross

Adage Capital Management
Andrew Hack Headshot

Andrew Hack

Bain Capital
Kris Jenner Headshot

Kris Jenner

Rock Springs Capital
Rajiv Kaul Headshot

Rajiv Kaul

Fidelity Investments
Oleg Nodelman Headshot

Oleg Nodelman

EcoR1 Capital
Jason Rhodes Headshot

Jason Rhodes

Atlas Ventures
Francesco De Rubertis Headshot

Francesco De Rubertis

Medicxi
Amy Schulman Headshot

Amy Schulman

Polaris Venture Partners
Amy Schulman Headshot

Otello Stampacchia

Omega Funds
Rebecca Sykes Headshot

Rebecca Sykes

Wellington

ABI25 at MIT Highlight Reel

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. For more information, visit www.royaltypharma.com.

Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine. For more information, visit https://ki.se/en/about

Nobel Prize Outreach’s mission is to inspire change guided by Alfred Nobel’s vision to work “for the greatest benefit to humankind”. We develop ambitious national and international outreach activities to disseminate knowledge on Nobel Prize-awarded achievements and to engage and inspire people to tackle the greatest challenges of our times, through conferences, educational programmes, student lectures, digital storytelling, podcasts and documentaries. Our events bring Nobel Prize laureates and world-leading experts to locations across the globe to discuss and engage audiences with the challenges of our future. We aim to encourage discussion at the highest level online as well as on-site. By bridging science, peace, literature and society, we provide an opportunity to stimulate thinking, excite imagination and inspire greatness. https://www.nobelprize.org/the-nobel-prize-organisation/digital-outreach/